Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|August 9, 2005
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patientsMasahide Fukudo, Ikuko Yano, Satohiro Masuda, et al.
Pharmaceutical Research|March 10, 2009
MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patientsKeiko Hosohata, Satohiro Masuda, Atsushi Yonezawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 14, 2009
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patientsKeiko Hosohata, Satohiro Masuda, Toshiya Katsura, et al.
Drug Metabolism and Pharmacokinetics|November 1, 2008
Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bileMasahiro Shimomura, Satohiro Masuda, Maki Goto, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 14, 2012
Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allograftsAya Miyagawa-Hayashino, Atushi Yoshizawa, Yoichiro Uchida, et al.
Inflammatory Bowel Diseases|September 18, 2010
Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitisTakuya Yoshino, Hiroshi Nakase, Yusuke Honzawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 4, 2020
[Significant Changes Associated with the Transition from Outsourcing to In-hospital Therapeutic Drug Monitoring of Novel Antiepileptics]Kimitaka Suetsugu, Nanae Yamamoto, Tomohiro Shigematsu, et al.
Pageof 16